Health | Nerves Fuel Pancreatic Cancer Growth, Hinting at New Therapies
Senior Technology Correspondent · AI, startups & MeitY policy
Quick summary
Researchers at Cold Spring Harbor Laboratory have uncovered a novel mechanism where nerve activity accelerates early pancreatic cancer growth, suggesting a promising new therapeutic approach. This discovery, published in Cancer Discovery, could offer new hope for battling this aggressive disease, with potential future implications for patients in India and globally.
LEDE PARAGRAPH
Researchers at Cold Spring Harbor Laboratory revealed on , a novel mechanism where nerve activity accelerates early pancreatic cancer growth, suggesting new therapeutic avenues. This discovery, published in Cancer Discovery, sheds light on the complex interplay between nerves and tumour development in one of the most aggressive cancers.
WHAT'S NEW / KEY FINDINGS
Scientists have identified a previously unknown mechanism in pancreatic cancer development, demonstrating that the nervous system actively contributes to its progression even before full tumours appear. Support cells within the pancreas, specifically tumour-promoting fibroblasts known as myCAFs, were found to release chemical signals that attract nerve fibres. These nerve fibres then release signals, such as the neurotransmitter norepinephrine, which further accelerate the growth of early-stage pancreatic cancer by activating the myCAFs, creating a "vicious cycle". Crucially, experiments demonstrated that blocking this specific nerve activity significantly reduced tumour growth, in some cases by nearly 50%, suggesting a new treatment strategy.
KEY DETAILS
The research, conducted by Jeremy Nigri and colleagues in Professor David Tuveson's lab at Cold Spring Harbor Laboratory, utilised advanced 3D imaging techniques like whole-mount immunofluorescence to visualise a dense network of nerves interacting with pancreatic lesions and myCAFs. This innovative imaging revealed how these myCAFs and nerve cells collaboratively create an environment that supports rapid cancer progression. The findings are particularly significant as they show the nervous system's involvement much earlier than the previously understood phenomenon of "perineural invasion," where cancer cells use nerves to metastasise.
EVIDENCE / SOURCE
This significant finding was reported by researchers at Cold Spring Harbor Laboratory on . The study's results were published in Cancer Discovery, a journal of the American Association for Cancer Research.
LIMITATIONS
While promising, these findings are from early-stage research primarily conducted in experiments on mice and human cells. Further research, including comprehensive clinical trials, is needed to confirm these results in humans and to translate them into effective therapies. The study suggests that existing drugs, such as doxazosin, might be effective in combination with standard chemotherapy by targeting this mechanism. However, their efficacy in this specific context needs to be rigorously evaluated. As with all new medical discoveries, it is important to consult a healthcare provider for personalised advice.
PRACTICAL TAKEAWAY
For patients and healthcare providers in India and globally, this research offers a glimmer of hope for a cancer known for its aggressive nature and poor prognosis. Understanding this nerve-tumour interaction could lead to the development of new drugs or the repurposing of existing ones that specifically target this mechanism, potentially improving treatment outcomes for pancreatic cancer in the future. This approach could complement standard treatments, offering a multi-pronged attack against the disease.
KEY TAKEAWAYS
- Researchers at Cold Spring Harbor Laboratory discovered a new mechanism where nerve activity actively fuels early pancreatic cancer growth.
- Tumour-promoting fibroblasts (myCAFs) attract sympathetic nerve fibres, which then release norepinephrine, creating a vicious cycle that accelerates tumour development.
- Experiments demonstrated that blocking this nerve activity significantly reduced tumour growth, in some cases by nearly 50%.
- This discovery, published in Cancer Discovery, suggests potential new therapeutic strategies, including the repurposing of existing drugs.
- This early-stage research is promising, but further clinical studies are necessary to develop human therapies.
PEOPLE ALSO ASK
What is pancreatic cancer?
Pancreatic cancer is a disease in which malignant cells form in the tissues of the pancreas, a gland located behind the stomach that produces enzymes for digestion and hormones like insulin. It is often aggressive and challenging to diagnose early and treat effectively.
How do nerves affect cancer growth?
Research indicates that nerves can actively influence cancer growth by releasing signals that promote tumour development and progression. This study shows that in pancreatic cancer, sympathetic nerve fibres release norepinephrine, which activates tumour-promoting cells (myCAFs), accelerating early-stage tumour growth.
What are the current treatments for pancreatic cancer?
Current treatments for pancreatic cancer typically include surgery, chemotherapy, radiation therapy, and targeted therapy, depending on the stage and type of cancer. Pancreatic cancer is known for being difficult to treat with standard therapies.
Will this new finding lead to immediate treatments for pancreatic cancer?
While this discovery is a significant step, it is from early-stage research. It suggests a potential new therapeutic approach but will require extensive further studies and clinical trials before any new treatments based on this mechanism become available to patients. Researchers hope it could lead to new combination therapies.
Last updated: